Sam Gray - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock Sam Gray’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
img
City/Area:

Social media:

Past investments:

  • Convergence Pharmaceuticals
  • Medical Imaging Partnership / Prime Health and Diagnostics
  • Kelso Pharma
  • Ulthera
  • Serentis
  • NIMGenetics
  • Medical Imaging Partnership
  • Ambit Biosciences
  • PharmaKodex
  • Bird Rock Bio
  • Mirada Medical
  • Cancer Partners UK
  • Ambrx
  • Anaphore

Investor Profile

Sam Gray is a Venture Capital, Private Equity Firm based in London, England, United Kingdom with a diverse investment portfolio that includes companies such as Convergence Pharmaceuticals, Medical Imaging Partnership / Prime Health and Diagnostics, Kelso Pharma, Ulthera, Serentis, NIMGenetics, Medical Imaging Partnership, Ambit Biosciences, PharmaKodex, Bird Rock Bio, Mirada Medical, Cancer Partners UK, Ambrx, Anaphore, . Over time, Sam Gray has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Sam Gray is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Wellness, Investment Management, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Automation, Software, Manufacturing, Biotechnology, Medical Devices, Cosmetics, Genomics, Neuroscience, Digital Transformation, Consulting, Hardware, Telehealth, Medical Diagnostics, Health Diagnostics, Social Impact, UK-based Startups, Digital Health, Medical, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Media and Entertainment, Pharmaceuticals, Acquisitions, Biometrics may find it worthwhile to explore potential connections with Sam Gray, as their portfolio suggests a familiarity and interest in this area.

Understanding Sam Gray’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today